Related Experiment Video

Updated: Sep 13, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Hepatitis C and human immunodeficiency virus infection

David L Thomas1

  • 1Viral Hepatitis Section, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD, USA. dt@jhmi.edu

Hepatology (Baltimore, Md.)
|October 31, 2002
PubMed

Insights

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection accelerates liver disease and complicates HIV treatment. Management requires careful consideration of both infections despite limited specific data.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection affects 200,000 individuals in the U.S.
  • HIV treatment advances have prolonged survival, making liver disease a leading cause of mortality in coinfected patients.
  • HIV exacerbates HCV progression and increases antiretroviral therapy-related liver toxicity.

Purpose of the Study:

  • To review the impact of HIV on HCV infection and vice versa.
  • To discuss the challenges and current controversies in managing HCV in HIV-coinfected individuals.
  • To highlight the need for evidence-based management strategies.

Main Methods:

  • Literature review and synthesis of existing data on HIV/HCV coinfection.
  • Analysis of the interplay between HIV and HCV disease progression.
  • Evaluation of treatment implications and toxicities.

Main Results:

  • HIV infection accelerates HCV-related liver disease progression and increases viral persistence.
  • HCV coinfection can increase the risk of liver toxicity from HIV antiretroviral medications.
  • Current management strategies are based on data from non-HIV-infected populations and understanding of both diseases.

Conclusions:

  • The significant burden of liver disease in coinfected individuals necessitates proactive management.
  • Further research and clinical trials are crucial for optimizing HCV treatment in coinfected patients.
  • Management should integrate knowledge of both infections, even with limited coinfection-specific data.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis00:10

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...